摘要
综述了使用相似或者不同技术的化合物对免疫肿瘤学药物进行的组合疗法研究。免疫肿瘤学组合疗法掀起了大型制药公司和规模较小的生物技术公司的研究热潮,它们已经开始对组合疗法用于癌症治疗进行了专门性测试。综述来源于汤森路透CortellisTM数据库的战略数据。
The imnauno-oncology drugs undergoing combination development with similar or variable techniques have been reviewed in this paper. Immuno-oncology combinations have led to a spate of researcb deals with big pharmaceutical companies and smaller biotcchs, and these companies have moved into ah＇nost exclusively testing combinations to treat cancer. This review is based on the strategic data from Thomson Reuters CortellisTM.
出处
《药学进展》
CAS
2015年第1期73-80,共8页
Progress in Pharmaceutical Sciences
